News
Videos
Conferences
Events
Resources
Subscribe

|Videos|September 22, 2017

What is the Gleason Score?

Newsletter

Stay up to date on cancer updates, research and education

Related Content

prostate cancer

Reflections 10 Years After a Prostate Cancer Diagnosis

ByNicholas DeMartino

January 1st 2026

The FDA has granted approval to treatment with Rubraca for some adult patients with previously-treated metastatic castration-resistant prostate cancer: © stock.adobe.com.

FDA Grants Regular Approval to Rubraca for Some With Prostate Cancer

December 17th 2025

Newly diagnosed with stage 3 prostate adenocarcinoma? Understand your diagnosis, explore multimodality treatment options, potential side effects, and key questions to ask your oncologist for an informed cancer journey.

Stage 3 Prostate Cancer: A Guide to Diagnosis, Treatment, and Next Steps

December 14th 2025

The FDA approved Akeega combination therapy for adults with BRCA2-mutated metastatic castration-sensitive prostate cancer.

FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer

BySpencer Feldman

December 12th 2025

In a recent interview with CURE, Dr. Kai Tsao discussed treatment advancements for patients with prostate cancer.

Breaking Down the Prostate Cancer Treatment Renaissance

December 9th 2025

Trending on CURE

CAR-T Therapy Helps Manhattan Attorney Achieve Complete Response For NSCLC

Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

Reflections 10 Years After a Prostate Cancer Diagnosis

Early Data Show INCA033989 Activity in Calreticulin-Driven Myelofibrosis

Thankful Heart: Gratitude for Support During Cancer